In one study, 60% of individuals expressing all three apoC-III variants together with an apoE variant experienced extreme hypertriglyceridaemia (greater than 7 mmol/l) when exposed to ritonavir, values more than two times those of patients with similar genetic profiles not on ART treatment [16]. The gene discussed is APOC3; the disease is hypertriglyceridemia.